Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-000842
Filing Date
2025-01-03
Accepted
2025-01-03 17:00:54
Documents
5
Effectiveness Date
2025-01-03

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm251759d1_s8.htm S-8 58020
2 EXHIBIT 5.1 tm251759d1_ex5-1.htm EX-5.1 12368
3 EXHIBIT 23.1 tm251759d1_ex23-1.htm EX-23.1 2441
4 EX-FILING FEES tm251759d1_ex-filingfees.htm EX-FILING FEES 10939
5 GRAPHIC tm251759d1_ex5-1img001.jpg GRAPHIC 15690
  Complete submission text file 0001104659-25-000842.txt   106546
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284132 | Film No.: 25507519
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)